🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Orofacial Pain Self-management: Personality Moderation Effect

RecruitingNAAges 18 Years - 65 YearsAllFundación Universidad Católica de Valencia San Vi…
NCT06932406 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The objective of this clinical trial is to study the effect of self-management on pain perception in patients with chronic orofacial pain and temporomandibular disorders (TMD) comparing it with the conventional treatment proposed by the TMD clinical practice guidelines. It also evaluates its effect on function and various psychosocial variables. As a secondary objective, this work proposes to study the variability between patients, in terms of personality factors, as moderators of the effect of treatment on pain perception. Including in the proposed statistical models certain covariates such as perception and/or coping with stress, anxiety and other psychosocial variables. This is a randomized clinical trial with two intervention groups and three measurement times (T0; pre-intervention, T1; post-5 weeks and T2; post-6 months). The experimental group will be applied a protocol based on

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * The patient presents TMDs diagnosed according to the CD/TMD classification. * Age between 18 and 65. * Presence of pain in mandibular, temporal, facial, peri-auricular and/or auricular regions. * Presence of chronic orofacial pain. Defined by the ICD-11 as orofacial pain or headache that occurs for more than two hours a day for 50% of the days of the last three months. * Orofacial pain is related to TMDs according to the International Classification of Headaches. * Moderate pain intensity, corresponding to a weekly average of at least 30 mm on a 100 mm VAS (validated representation of moderate pain on the VAS scale = 31-54 mm) Exclusion Criteria: * Concomitant rheumatic systemic pathologies. * History of trauma or recent surgical intervention in the head, face, neck or chest. * Presence of intraoral infections or odontogenic pain. * Headache of neuropathic origin (trigeminal neuralgia, Arnold neuralgia, etc.). * Being receiving therapy (except rescue pharmacological therapy) for this disorder or pain. * Cognitive impairment that prevents the follow-up of an educational program (determined through the MoCA questionnaire)
💊

What it tests

  • Self-management intervention
  • Clinical Practice Guideline Intervention
📍

Where

1 site
Catholic Univerity of Valencia
Valencia, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy